Skip to main content

Table 3 Descriptive data on samples included in the statistical analysis of cat sera (n = 266) tested for the rabies antibody response after vaccination in Finland during 2009–2013

From: Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2

Variable

Levels

Antibody response

< 0.5 IU/ml (n = 25)

Antibody response

≥ 0.5 IU/ml (n = 241)

n

% (95% CI)

n

% (95% CI)

Age at vaccination (year)

 ≤ 1

12

48.0 (29.5–66.9)

47

19.6 (14.9–25.0)

 > 1

13

52.0 (33.1–70.5)

193

80.4 (75.0–85.1)

Gender

 Female

5

20.0 (8.1–38.4)

89

58.6 (50.6–66.2)

 Male

8

32.0 (16.4–51.5)

63

26.1 (20.9–31.9)

Number of vaccinations

 Once

24

96.0 (82.8–99.6)

194

80.5 (75.5–85.5)

 Twice

1

4.0 (0.4–17.2)

42

17.4 (13.0–22.6)

 More than twice

0

0.0 (0–9.5)

5

2.1 (0.8–4.5)

Time btw vaccination and sampling (months)

 < 3

1

5.3 (0.6–22.1)

78

42.2 (35.2–49.4)

 3–6

8

42.1 (22.3–64.1)

70

37.8 (31.1–45.0)

 > 6

10

52.6 (31.2–73.4)

37

20.0 (14.7–26.2)

Vaccine used

 Only vaccine Wistar-G52

3

25.0 (7.6–52.9)

39

25.7 (19.2–33.0)

 Only vaccine Pasteur RIV

1

8.3 (0.9–32.8)

63

41.4 (33.8–49.4)

 Only vaccine Flury LEP

6

50.0 (24.3–75.7)

25

16.4 (11.2–22.9)

 Other

2

16.7 (3.6–43.6)

25

16.4 (11.2–22.9)

  1. CI confidence interval, n number of cases